MGMT and glioblastoma: MGMT promoter methylation is the most predictive factor associated with longer survival in patients with glioblastoma who receive TMZ, and the gene microarray showed that the expression of MGMT was not changed after indirect coculture with gaMSCs (P > 0.05).